TreeWAS – Variant ID: rs12576239

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E11.5 With peripheral circulatory complications	0.000	0.954	0.046
E11 Non-insulin-dependent diabetes mellitus	0.000	0.955	0.045
E11.3 With ophthalmic complications	0.000	0.955	0.045
E11.4 With neurological complications	0.000	0.956	0.044
E11.0 With coma	0.000	0.965	0.035
E11.1 With ketoacidosis	0.000	0.965	0.035
E11.2 With renal complications	0.000	0.965	0.035
E11.6 With other specified complications	0.000	0.966	0.034
E11.7 With multiple complications	0.000	0.967	0.033
E11.8 With unspecified complications	0.000	0.969	0.031
N35.9 Urethral stricture, unspecified	0.025	0.975	0.000
N35 Urethral stricture	0.024	0.976	0.000
N31.9 Neuromuscular dysfunction of bladder, unspecified	0.023	0.977	0.000
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.023	0.977	0.000
N30-N39 Other diseases of urinary system	0.022	0.978	0.000
N35.8 Other urethral stricture	0.021	0.979	0.000
N36 Other disorders of urethra	0.021	0.979	0.000
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.020	0.980	0.000
N39.4 Other specified urinary incontinence	0.019	0.981	0.000
N36.8 Other specified disorders of urethra	0.019	0.981	0.000
N36.2 Urethral caruncle	0.018	0.982	0.000
N31.8 Other neuromuscular dysfunction of bladder	0.018	0.982	0.000
N35.1 Postinfective urethral stricture, not elsewhere classified	0.017	0.983	0.000
N35.0 Posttraumatic urethral stricture	0.017	0.983	0.000
N39 Other disorders of urinary system	0.017	0.983	0.000
N31.1 Reflex neuropathic bladder, not elsewhere classified	0.017	0.983	0.000
N31.0 Uninhibited neuropathic bladder, not elsewhere classified	0.017	0.983	0.000
N36.9 Urethral disorder, unspecified	0.017	0.983	0.000
N37 Urethral disorders in diseases classified elsewhere	0.016	0.984	0.000
N33 Bladder disorders in diseases classified elsewhere	0.016	0.984	0.000
N39.8 Other specified disorders of urinary system	0.015	0.985	0.000
N36.1 Urethral diverticulum	0.015	0.985	0.000
E04.2 Non-toxic multinodular goitre	0.015	0.985	0.000
N36.3 Prolapsed urethral mucosa	0.014	0.986	0.000
H11.4 Other conjunctival vascular disorders and cysts	0.000	0.986	0.014
N36.0 Urethral fistula	0.013	0.987	0.000
N39.1 Persistent proteinuria, unspecified	0.013	0.987	0.000
H11 Other disorders of conjunctiva	0.000	0.987	0.013
E04 Other non-toxic goitre	0.013	0.987	0.000
H11.9 Disorder of conjunctiva, unspecified	0.000	0.987	0.013
E04.1 Non-toxic single thyroid nodule	0.012	0.988	0.000
N39.2 Orthostatic proteinuria, unspecified	0.012	0.988	0.000
N32 Other disorders of bladder	0.012	0.988	0.000
N30 Cystitis	0.012	0.988	0.000
N33.8 Bladder disorders in other diseases classified elsewhere	0.011	0.988	0.000
N33.0 Tuberculous cystitis	0.011	0.988	0.000
N37.8 Other urethral disorders in diseases classified elsewhere	0.011	0.988	0.000
N37.0 Urethritis in diseases classified elsewhere	0.011	0.988	0.000
H11.0 Pterygium	0.000	0.988	0.011
N34 Urethritis and urethral syndrome	0.011	0.989	0.000
E04.0 Non-toxic diffuse goitre	0.011	0.989	0.000
H11.3 Conjunctival haemorrhage	0.000	0.989	0.010
N32.9 Bladder disorder, unspecified	0.010	0.990	0.000
N30.8 Other cystitis	0.010	0.990	0.000
E04.9 Non-toxic goitre, unspecified	0.010	0.990	0.000
H11.1 Conjunctival degenerations and deposits	0.000	0.990	0.010
N30.1 Interstitial cystitis (chronic)	0.010	0.990	0.000
N32.3 Diverticulum of bladder	0.010	0.990	0.000
H11.2 Conjunctival scars	0.000	0.991	0.009
E04.8 Other specified non-toxic goitre	0.009	0.991	0.000
N32.2 Vesical fistula, not elsewhere classified	0.009	0.991	0.000
N32.4 Rupture of bladder, nontraumatic	0.009	0.991	0.000
N32.1 Vesicointestinal fistula	0.009	0.991	0.000
N34.1 Nonspecific urethritis	0.008	0.992	0.000
N34.0 Urethral abscess	0.008	0.992	0.000
N30.2 Other chronic cystitis	0.008	0.992	0.000
N30.3 Trigonitis	0.008	0.992	0.000
N32.8 Other specified disorders of bladder	0.008	0.992	0.000
N34.3 Urethral syndrome, unspecified	0.007	0.992	0.000
N30.4 Irradiation cystitis	0.007	0.992	0.000
H11.8 Other specified disorders of conjunctiva	0.000	0.993	0.007
N30.9 Cystitis, unspecified	0.007	0.993	0.000
Y42.7 Androgens and anabolic congeners	0.007	0.993	0.000
E10-E14 Diabetes mellitus	0.000	0.993	0.007
N30.0 Acute cystitis	0.006	0.994	0.000
K85.9 Acute pancreatitis, unspecified	0.000	0.994	0.006
N34.2 Other urethritis	0.005	0.994	0.001
E12 Malnutrition-related diabetes mellitus	0.000	0.995	0.005
E14 Unspecified diabetes mellitus	0.000	0.995	0.005
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.005	0.995	0.000
E11.9 Without complications	0.000	0.995	0.005
I85.9 Oesophageal varices without bleeding	0.005	0.995	0.000
Z96.8 Presence of other specified functional implants	0.000	0.995	0.005
E14.9 Without complications	0.000	0.995	0.005
K85.1 Biliary acute pancreatitis	0.000	0.996	0.004
E13 Other specified diabetes mellitus	0.000	0.996	0.004
Y42.0 Glucocorticoids and synthetic analogs	0.004	0.996	0.000
J18.0 Bronchopneumonia, unspecified	0.000	0.996	0.004
Z85.1 Personal history of malignant neoplasm of trachea, bronchus and lung	0.004	0.996	0.000
I31.9 Disease of pericardium, unspecified	0.004	0.996	0.000
K85 Acute pancreatitis	0.000	0.996	0.004
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.004	0.996	0.000
E12.9 Without complications	0.000	0.996	0.004
E12.8 With unspecified complications	0.000	0.996	0.004
E12.7 With multiple complications	0.000	0.996	0.004
E12.6 With other specified complications	0.000	0.996	0.004
E12.5 With peripheral circulatory complications	0.000	0.996	0.004
E12.4 With neurological complications	0.000	0.996	0.004
E12.3 With ophthalmic complications	0.000	0.996	0.004
E12.2 With renal complications	0.000	0.996	0.004
E12.1 With ketoacidosis	0.000	0.996	0.004
E12.0 With coma	0.000	0.996	0.004
E14.7 With multiple complications	0.000	0.996	0.004
E14.6 With other specified complications	0.000	0.996	0.004
E14.5 With peripheral circulatory complications	0.000	0.996	0.004
E14.2 Withrenal complications	0.000	0.996	0.004
E14.1 With ketoacidosis	0.000	0.996	0.004
E14.0 With coma	0.000	0.996	0.004
Y42.9 Other and unspecified hormone antagonists	0.004	0.996	0.000
Y42.4 Oral contraceptives	0.004	0.996	0.000
Y42.2 Antithyroid drugs	0.004	0.996	0.000
Y42.1 Thyroid hormones and substitutes	0.004	0.996	0.000
Y42.5 Other oestrogens and progestogens	0.004	0.996	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.996	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.003	0.996	0.000
H10-H13 Disorders of conjunctiva	0.000	0.996	0.003
E14.4 With neurological complications	0.000	0.996	0.003
Z50.4 Psychotherapy, not elsewhere classified	0.003	0.997	0.000
E13.8 With unspecified complications	0.000	0.997	0.003
E13.7 With multiple complications	0.000	0.997	0.003
E13.6 With other specified complications	0.000	0.997	0.003
E13.5 With peripheral circulatory complications	0.000	0.997	0.003
E13.4 With neurological complications	0.000	0.997	0.003
E13.3 With ophthalmic complications	0.000	0.997	0.003
E13.2 With renal complications	0.000	0.997	0.003
E13.1 With ketoacidosis	0.000	0.997	0.003
E13.0 With coma	0.000	0.997	0.003
E14.3 With ophthalmic complications	0.000	0.997	0.003
N39.9 Disorder of urinary system, unspecified	0.003	0.997	0.000
K85.3 Drug-induced acute pancreatitis	0.000	0.997	0.003
K85.2 Alcohol-induced acute pancreatitis	0.000	0.997	0.003
K85.0 Idiopathic acute pancreatitis	0.000	0.997	0.003
I85.0 Oesophageal varices with bleeding	0.003	0.997	0.000
I85 Oesophageal varices	0.003	0.997	0.000
E14.8 With unspecified complications	0.000	0.997	0.003
S02.50 Fracture of tooth (closed)	0.003	0.997	0.000
K85.8 Other acute pancreatitis	0.000	0.997	0.003
I31 Other diseases of pericardium	0.003	0.997	0.000
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters	0.000	0.997	0.003
H80.9 Otosclerosis, unspecified	0.003	0.997	0.000
I31.1 Chronic constrictive pericarditis	0.003	0.997	0.000
E21.3 Hyperparathyroidism, unspecified	0.003	0.997	0.000
Q61.2 Polycystic kidney, adult type	0.000	0.997	0.003
H13 Disorders of conjunctiva in diseases classified elsewhere	0.000	0.997	0.003
E13.9 Without complications	0.000	0.997	0.003
I31.3 Pericardial effusion (noninflammatory)	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)	0.003	0.997	0.000
J35.0 Chronic tonsillitis	0.000	0.997	0.003
D45 Polycythaemia vera	0.003	0.997	0.000
I31.0 Chronic adhesive pericarditis	0.002	0.998	0.000
I31.8 Other specified diseases of pericardium	0.002	0.998	0.000
I31.2 Haemopericardium, not elsewhere classified	0.002	0.998	0.000
S06.20 Diffuse brain injury (without open intracranial wound)	0.002	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.002	0.998	0.000
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
E00-E07 Disorders of thyroid gland	0.002	0.998	0.000
H13.8 Other disorders of conjunctiva in diseases classified elsewhere	0.000	0.998	0.002
H13.3 Ocular pemphigoid	0.000	0.998	0.002
H13.2 Conjunctivitis in other diseases classified elsewhere	0.000	0.998	0.002
H13.1 Conjunctivitis in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
H13.0 Filarial infection of conjunctiva	0.000	0.998	0.002
H20.9 Iridocyclitis, unspecified	0.000	0.998	0.002
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries	0.002	0.998	0.000
C71.9 Brain, unspecified	0.000	0.998	0.002
I63.8 Other cerebral infarction	0.002	0.998	0.000
S06.5 Traumatic subdural haemorrhage	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
C71.3 Parietal lobe	0.000	0.998	0.002
C71 Malignant neoplasm of brain	0.000	0.998	0.002
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.002	0.998	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
C71.0 Cerebrum, except lobes and ventricles	0.000	0.998	0.002
S06.2 Diffuse brain injury	0.002	0.998	0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.002	0.998	0.000
C71.8 Overlapping lesion of brain	0.000	0.998	0.002
Q61.3 Polycystic kidney, unspecified	0.000	0.998	0.002
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.002	0.998	0.000
E06 Thyroiditis	0.002	0.998	0.000
H10 Conjunctivitis	0.001	0.998	0.002
C71.2 Temporal lobe	0.000	0.998	0.002
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
Z13.9 Special screening examination, unspecified	0.002	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
Q61 Cystic kidney disease	0.000	0.998	0.002
E07 Other disorders of thyroid	0.002	0.998	0.000
I63.0 Cerebral infarction due to thrombosis of precerebral arteries	0.002	0.998	0.000
L92.3 Foreign body granuloma of skin and subcutaneous tissue	0.002	0.998	0.000
S06.6 Traumatic subarachnoid haemorrhage	0.002	0.998	0.000
Y49.2 Other and unspecified antidepressants	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
E07.8 Other specified disorders of thyroid	0.002	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
I25.8 Other forms of chronic ischaemic heart disease	0.000	0.998	0.002
L98.9 Disorder of skin and subcutaneous tissue, unspecified	0.002	0.998	0.000
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters	0.000	0.998	0.002
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.002	0.998	0.000
E00 Congenital iodine-deficiency syndrome	0.002	0.998	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.002	0.998	0.000
I67.9 Cerebrovascular disease, unspecified	0.002	0.998	0.000
S06 Intracranial injury	0.002	0.998	0.000
E06.3 Autoimmune thyroiditis	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
I63 Cerebral infarction	0.002	0.998	0.000
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)	0.002	0.998	0.000
C71.7 Brain stem	0.000	0.998	0.002
C71.6 Cerebellum	0.000	0.998	0.002
C71.5 Cerebral ventricle	0.000	0.998	0.002
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
J35.1 Hypertrophy of tonsils	0.000	0.998	0.002
C71.1 Frontal lobe	0.000	0.998	0.002
J35.9 Chronic disease of tonsils and adenoids, unspecified	0.000	0.998	0.002
N32.0 Bladder-neck obstruction	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.7 Agents affecting calcification	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
C71.4 Occipital lobe	0.000	0.998	0.002
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
Y53.4 Other laxatives	0.002	0.998	0.000
S06.21 Diffuse brain injury (with open intracranial wound)	0.002	0.998	0.000
I63.4 Cerebral infarction due to embolism of cerebral arteries	0.002	0.998	0.000
J35 Chronic diseases of tonsils and adenoids	0.000	0.998	0.002
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
E06.9 Thyroiditis, unspecified	0.002	0.998	0.000
E06.5 Other chronic thyroiditis	0.002	0.998	0.000
E06.4 Drug-induced thyroiditis	0.002	0.998	0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.002	0.998	0.000
E06.1 Subacute thyroiditis	0.002	0.998	0.000
E06.0 Acute thyroiditis	0.002	0.998	0.000
H10.8 Other conjunctivitis	0.001	0.998	0.001
H10.5 Blepharoconjunctivitis	0.001	0.998	0.001
H10.3 Acute conjunctivitis, unspecified	0.001	0.998	0.001
H10.2 Other acute conjunctivitis	0.001	0.998	0.001
H10.1 Acute atopic conjunctivitis	0.001	0.998	0.001
H10.0 Mucopurulent conjunctivitis	0.001	0.998	0.001
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
S06.3 Focal brain injury	0.002	0.998	0.000
Y28.9 Unspecified place	0.002	0.998	0.000
E07.1 Dyshormogenetic goitre	0.002	0.998	0.000
E07.0 Hypersecretion of calcitonin	0.002	0.998	0.000
Q61.9 Cystic kidney disease, unspecified	0.000	0.998	0.002
Q61.8 Other cystic kidney diseases	0.000	0.998	0.002
Q61.5 Medullary cystic kidney	0.000	0.998	0.002
Q61.4 Renal dysplasia	0.000	0.998	0.002
Q61.1 Polycystic kidney, infantile type	0.000	0.998	0.002
S06.9 Intracranial injury, unspecified	0.002	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.001	0.998	0.000
S06.61 Traumatic subarachnoid haemorrhage (with open intracranial wound)	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.001	0.998	0.000
Y50.8 Other central nervous system stimulants	0.001	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.001	0.998	0.000
Y50.1 Opioid receptor antagonists	0.001	0.998	0.000
Y50.0 Analeptics	0.001	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
O23.4 Unspecified infection of urinary tract in pregnancy	0.002	0.998	0.000
Q61.0 Congenital single renal cyst	0.000	0.998	0.002
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.001	0.998	0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.001	0.998	0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.001	0.998	0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.001	0.998	0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.001	0.998	0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.001	0.998	0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.001	0.998	0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.001	0.998	0.000
H36.0 Diabetic retinopathy	0.000	0.998	0.002
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk	0.002	0.998	0.000
S06.8 Other intracranial injuries	0.002	0.998	0.000
Y54.5 Other diuretics	0.002	0.998	0.000
S02.5 Fracture of tooth	0.002	0.998	0.000
S06.7 Intracranial injury with prolonged coma	0.002	0.998	0.000
S06.1 Traumatic cerebral oedema	0.002	0.998	0.000
H10.4 Chronic conjunctivitis	0.001	0.998	0.001
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic	0.002	0.998	0.000
I63.1 Cerebral infarction due to embolism of precerebral arteries	0.002	0.998	0.000
Y41.0 Sulphonamides	0.001	0.998	0.000
N10 Acute tubulo-interstitial nephritis	0.000	0.998	0.002
S50.9 Superficial injury of forearm, unspecified	0.002	0.998	0.000
M43.17 Spondylolisthesis (Lumbosacral region)	0.000	0.998	0.002
V11.4 Driver injured in traffic accident	0.002	0.998	0.000
S06.30 Focal brain injury (without open intracranial wound)	0.001	0.998	0.000
V18.2 Unspecified pedal cyclist injured in nontraffic accident	0.002	0.998	0.000
J35.3 Hypertrophy of tonsils with hypertrophy of adenoids	0.000	0.998	0.001
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.001	0.998	0.000
Y41.4 Anthelminthics	0.001	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.001	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.001	0.998	0.000
Y41.1 Antimycobacterial drugs	0.001	0.998	0.000
H80 Otosclerosis	0.002	0.998	0.000
S06.90 Intracranial injury, unspecified (without open intracranial wound)	0.001	0.998	0.000
D16.4 Bones of skull and face	0.002	0.998	0.000
N80.3 Endometriosis of pelvic peritoneum	0.000	0.998	0.002
Y41.5 Antiviral drugs	0.001	0.998	0.000
Z01.8 Other specified special examinations	0.000	0.998	0.002
C18.9 Colon, unspecified	0.000	0.998	0.002
D16.9 Bone and articular cartilage, unspecified	0.001	0.998	0.000
Y48.5 Therapeutic gases	0.001	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.001	0.998	0.000
Y48.1 Parenteral anaesthetics	0.001	0.998	0.000
Y48.0 Inhaled anaesthetics	0.001	0.998	0.000
S06.0 Concussion	0.001	0.998	0.000
S06.31 Focal brain injury (with open intracranial wound)	0.001	0.998	0.000
J35.2 Hypertrophy of adenoids	0.000	0.998	0.001
S50.0 Contusion of elbow	0.001	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.001	0.998	0.000
N61 Inflammatory disorders of breast	0.002	0.998	0.000
M13.90 Arthritis, unspecified (Multiple sites)	0.000	0.998	0.002
S06.91 Intracranial injury, unspecified (with open intracranial wound)	0.001	0.998	0.000
Y56.9 Topical agent, unspecified	0.001	0.998	0.000
Y56.8 Other topical agents	0.001	0.998	0.000
Y56.7 Dental drugs, topically applied	0.001	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.001	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.001	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.001	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.001	0.998	0.000
Y56.2 Local astringents and local detergents	0.001	0.998	0.000
Y56.1 Antipruritics	0.001	0.998	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.002	0.998	0.000
D16.5 Lower jaw bone	0.001	0.998	0.000
E21.2 Other hyperparathyroidism	0.001	0.998	0.000
L02.1 Cutaneous abscess, furuncle and carbuncle of neck	0.001	0.998	0.000
B98 Other specified infectious agents as the cause of diseases classified to other chapters	0.000	0.998	0.001
M47.92 Spondylosis, unspecified (Cervical region)	0.001	0.999	0.000
S06.81 Other intracranial injuries (with open intracranial wound)	0.001	0.999	0.000
S06.80 Other intracranial injuries (without open intracranial wound)	0.001	0.999	0.000
J35.8 Other chronic diseases of tonsils and adenoids	0.000	0.999	0.001
S02.51 Fracture of tooth (open)	0.001	0.999	0.000
S06.11 Traumatic cerebral oedema (with open intracranial wound)	0.001	0.999	0.000
S06.10 Traumatic cerebral oedema (without open intracranial wound)	0.001	0.999	0.000
S06.71 Intracranial injury with prolonged coma (with open intracranial wound)	0.001	0.999	0.000
S06.70 Intracranial injury with prolonged coma (without open intracranial wound)	0.001	0.999	0.000
J45.0 Predominantly allergic asthma	0.001	0.999	0.000
L30.9 Dermatitis, unspecified	0.000	0.999	0.001
S06.4 Epidural haemorrhage	0.001	0.999	0.000
V89.2 Person injured in unspecified motor-vehicle accident, traffic	0.001	0.999	0.000
X59.4 Street and highway	0.001	0.999	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.001	0.999	0.000
E07.9 Disorder of thyroid, unspecified	0.001	0.999	0.000
K92.9 Disease of digestive system, unspecified	0.001	0.999	0.000
L02.0 Cutaneous abscess, furuncle and carbuncle of face	0.001	0.999	0.000
V11 Pedal cyclist injured in collision with other pedal cycle	0.001	0.999	0.000
H10.9 Conjunctivitis, unspecified	0.001	0.999	0.001
Y44.2 Anticoagulants	0.001	0.999	0.000
Z83.3 Family history of diabetes mellitus	0.000	0.999	0.001
Y40 Systemic antibiotics	0.001	0.999	0.000
H80.8 Other otosclerosis	0.001	0.999	0.000
H80.2 Cochlear otosclerosis	0.001	0.999	0.000
H80.1 Otosclerosis involving oval window, obliterative	0.001	0.999	0.000
H80.0 Otosclerosis involving oval window, nonobliterative	0.001	0.999	0.000
X59.2 School, other institution and public administrative area	0.001	0.999	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.999	0.001
X59 Exposure to unspecified factor	0.001	0.999	0.000
D16 Benign neoplasm of bone and articular cartilage	0.001	0.999	0.000
S50 Superficial injury of forearm	0.001	0.999	0.000
Y28 Contact with sharp object, undetermined intent	0.001	0.999	0.000
S06.01 Concussion (with open intracranial wound)	0.001	0.999	0.000
E55.9 Vitamin D deficiency, unspecified	0.001	0.999	0.000
L92.0 Granuloma annulare	0.001	0.999	0.000
N03.9 Unspecified	0.000	0.999	0.001
D16.2 Long bones of lower limb	0.001	0.999	0.000
D16.0 Scapula and long bones of upper limb	0.001	0.999	0.000
L92.8 Other granulomatous disorders of skin and subcutaneous tissue	0.001	0.999	0.000
Y48.3 Local anaesthetics	0.001	0.999	0.000
B98.1 Vibrio vulnificus as the cause of diseases classified to other chapters	0.000	0.999	0.001
E21.5 Disorder of parathyroid gland, unspecified	0.001	0.999	0.000
E21.4 Other specified disorders of parathyroid gland	0.001	0.999	0.000
H20.0 Acute and subacute iridocyclitis	0.000	0.999	0.001
G91.9 Hydrocephalus, unspecified	0.001	0.999	0.000
X59.3 Sports and athletics area	0.001	0.999	0.000
Z74.0 Reduced mobility	0.001	0.999	0.000
V18 Pedal cyclist injured in noncollision transport accident	0.001	0.999	0.000
S06.41 Epidural haemorrhage (with open intracranial wound)	0.001	0.999	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.001	0.999	0.000
X84.9 Unspecified place	0.001	0.999	0.000
G83.9 Paralytic syndrome, unspecified	0.001	0.999	0.000
S99.9 Unspecified injury of ankle and foot	0.001	0.999	0.000
V11.9 Unspecified pedal cyclist injured in traffic accident	0.001	0.999	0.000
V11.5 Passenger injured in traffic accident	0.001	0.999	0.000
V11.3 Person injured while boarding or alighting	0.001	0.999	0.000
V11.2 Unspecified pedal cyclist injured in nontraffic accident	0.001	0.999	0.000
V11.1 Passenger injured in nontraffic accident	0.001	0.999	0.000
V11.0 Driver injured in nontraffic accident	0.001	0.999	0.000
Y40.7 Antifungal antibiotics, systemically used	0.001	0.999	0.000
Y40.6 Rifamycins	0.001	0.999	0.000
Y40.5 Aminoglycosides	0.001	0.999	0.000
Y40.4 Tetracyclines	0.001	0.999	0.000
Y40.2 Chloramphenicol group	0.001	0.999	0.000
D16.8 Pelvic bones, sacrum and coccyx	0.001	0.999	0.000
D16.7 Ribs, sternum and clavicle	0.001	0.999	0.000
D16.6 Vertebral column	0.001	0.999	0.000
O72.2 Delayed and secondary postpartum haemorrhage	0.000	0.999	0.001
X59.9 Unspecified place	0.001	0.999	0.000
X59.8 Other specified place	0.001	0.999	0.000
X59.0 Home	0.001	0.999	0.000
X59.7 Farm	0.001	0.999	0.000
X59.6 Industrial and construction area	0.001	0.999	0.000
X59.5 Trade and service area	0.001	0.999	0.000
X59.1 Residential institution	0.001	0.999	0.000
Y28.5 Trade and service area	0.001	0.999	0.000
Y28.8 Other specified place	0.001	0.999	0.000
Y28.7 Farm	0.001	0.999	0.000
Y28.6 Industrial and construction area	0.001	0.999	0.000
Y28.4 Street and highway	0.001	0.999	0.000
Y28.3 Sports and athletics area	0.001	0.999	0.000
Y28.2 School, other institution and public administrative area	0.001	0.999	0.000
Y28.1 Residential institution	0.001	0.999	0.000
Y28.0 Home	0.001	0.999	0.000
H20 Iridocyclitis	0.000	0.999	0.001
L92 Granulomatous disorders of skin and subcutaneous tissue	0.001	0.999	0.000
D16.1 Short bones of upper limb	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations